Citation Impact

Citing Papers

Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
2016 Standout
Upregulation of PD-L1 via HMGB1-Activated IRF3 and NF-κB Contributes to UV Radiation-Induced Immune Suppression
2019
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40–Mediated Tumor Rejection
2016 StandoutNobel
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer
2018
CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
2018
Carotenoids: biochemistry, pharmacology and treatment
2016 Standout
Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells
2017
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Immunotherapy of melanoma
2013
Cardiotoxicity of immune checkpoint inhibitors
2017
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
2020 Standout
Delivering safer immunotherapies for cancer
2017
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Radiotherapy for renal-cell carcinoma
2014
CD56 in the Immune System: More Than a Marker for Cytotoxicity?
2017
Determining cell type abundance and expression from bulk tissues with digital cytometry
2019 Standout
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
2016
Pancreatic cancer
2004 Standout
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
2019
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
A proteomic atlas of senescence-associated secretomes for aging biomarker development
2020 Standout
Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research
2018
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes
2014
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Current Clinical Trials Testing Combinations of Immunotherapy and Radiation
2014
Adrenal insufficiency
2014
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Supplementation of xanthophylls decreased proinflammatory and increased anti-inflammatory cytokines in hens and chicks
2012
The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy
2013
Hepatocellular carcinoma
2021 Standout
Radiation as an immunological adjuvant: current evidence on dose and fractionation
2012
The immune contexture in cancer prognosis and treatment
2017 Standout
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
2014 Standout
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
The confluence of radiotherapy and immunotherapy
2012
Genetics of Type 1 Diabetes
2012
Delivery technologies for cancer immunotherapy
2019 Standout
Gut microbiome and health: mechanistic insights
2022 Standout
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling
2019
Use of tumour-responsive T cells as cancer treatment
2009
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence
2017
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Frameshift events predict anti–PD-1/L1 response in head and neck cancer
2018
Stereotactic Ablative Radiotherapy for Centrally Located Early Stage Non–Small-Cell Lung Cancer: What We Have Learned
2014
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
CD4:8 Ratio Above 5 Is Associated With All-Cause Mortality in CMV-Seronegative Very Old Women: Results From the BELFRAIL Study
2016
Current clinical trials testing the combination of immunotherapy with radiotherapy
2016
Revisiting the gut–joint axis: links between gut inflammation and spondyloarthritis
2020
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis
2020 StandoutNobel
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Plasma proteomic signature of age in healthy humans
2018
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Regulation of type I interferon responses
2013 Standout
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Standardizing immunophenotyping for the Human Immunology Project
2012
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Pancreatic cancer
2011 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
The intersection of radiotherapy and immunotherapy: Mechanisms and clinical implications
2016
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
2013
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
2016
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
2020
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?
2014 StandoutNobel
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
2016
New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology
2013
Emerging Opportunities and Challenges in Cancer Immunotherapy
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
2017
Development of immune checkpoint therapy for cancer
2019
Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients
2016
A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
2012
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Adrenal Steroidogenesis after B Lymphocyte Depletion Therapy in New-Onset Addison's Disease
2012
Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma
2016

Works of Janet Siebert being referenced

PD-1 Blockade Expands Intratumoral Memory T Cells
2016
Functional T Cell Responses to Tumor Antigens in Breast Cancer Patients Have a Distinct Phenotype and Cytokine Signature
2007
Functional intraepithelial lymphocyte changes in inflammatory bowel disease and spondyloarthritis have disease specific correlations with intestinal microbiota
2018
Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging
2015
The HLA-B*3906 allele imparts a high risk of diabetes only on specific HLA-DR/DQ haplotypes
2011
Dominant Suppression of Addison's Disease Associated with HLA-B15
2011
Monitoring Cytokine Profiles During Immunotherapy
2010
Haplotype Analysis Discriminates Genetic Risk for DR3-Associated Endocrine Autoimmunity and Helps Define Extreme Risk for Addison’s Disease
2010
Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses
2012
Rankless by CCL
2026